-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
OptimizeRx Corp annual Current Federal Tax Expense (Benefit) history and growth rate from 2013 to 2023.
- OptimizeRx Corp annual Current Federal Tax Expense (Benefit) for 2023 was $5.28 M, a 120% increase from 2022.
- OptimizeRx Corp annual Current Federal Tax Expense (Benefit) for 2022 was $2.4 M.
- OptimizeRx Corp annual Current Federal Tax Expense (Benefit) for 2021 was -$79 K, a 117% decline from 2020.
Current Federal Tax Expense (Benefit), Annual (USD)
Current Federal Tax Expense (Benefit), YoY Annual Growth (%)